Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins.

Previous investigations (El Mestikawy et al., J Neurochem 51: 1031-1040, 1988) have shown that 5-HT1A binding sites (R[5-HT1A]) solubilized by CHAPS from rat hippocampal membranes can be modulated by guanine nucleotides, as expected from their solubilization together with associated G regulatory proteins (G). Studies of the hydrodynamic properties of solubilized R[5-HT1A] have been presently carried out in order to assess in a more direct way the presence of R[5-HT1A]-G complexes in the soluble extract. Under control conditions, the sedimentation of a CHAPS extract from hippocampal membranes through a 5-30% sucrose gradient (200,000 g, 17 hr, 4 degrees) gave two maxima of [3H]8-OH-DPAT binding activity corresponding to sedimentation coefficients of 8.0 S and 10.0 S, respectively. Running the gradient in the presence of 1 microM GTP revealed a significant reduction of the 10.0 S peak, as expected from the loss of material (probably a G protein) normally associated with R[5-HT1A]. Conversely, attempts to prevent the dissociation of R[5-HT1A]-G by treatment of CHAPS soluble hippocampal extracts with the cross-linking reagent disuccinimidyl suberate (0.1 mM) resulted in a significant increase (+70%) in [3H]8-OH-DPAT binding activity associated with the appearance of a new sedimenting material with a higher coefficient (16.5 S). Furthermore, [3H]8-OH-DPAT binding became almost completely insensitive to guanine nucleotides as expected from the irreversible coupling by disuccinimidyl suberate of R[5-HT1A] with G protein(s). WGA-agarose chromatography of CHAPS soluble hippocampal extract supplemented with GTP allowed the physical separation of R[5-HT1A] from the bulk of G proteins, and a concomitant decrease of [3H]8-OH-DPAT high affinity binding capacity. Partial recovery of the latter could be achieved by reconstituting R[5-HT1A]-G complexes upon the addition of a mixture of pure bovine Gi + Go to G-deprived soluble extracts. Finally in vivo treatment with Pertussis toxin (5 micrograms intracerebroventricularly, 48 hr before killing) resulted in a significant reduction of the specific binding of [3H]8-OH-DPAT (-36%) to hippocampal membranes and corresponding CHAPS soluble extracts, and a marked decrease in the inhibitory effect of GppNHp. Accordingly the G protein associated with R[5-HT1A] belongs probably to the Gi or Go families.

[1]  Y. Kitamura,et al.  Effects of pertussis toxin on the alpha 2-adrenoceptor-inhibitory GTP-binding protein-adenylate cyclase system in rat brain: pharmacological and neurochemical studies. , 1987, European Journal of Pharmacology.

[2]  M. Caron,et al.  The D2-dopamine receptor of anterior pituitary is functionally associated with a pertussis toxin-sensitive guanine nucleotide binding protein. , 1987, The Journal of biological chemistry.

[3]  M. Hamon,et al.  [3H]8‐Hydroxy‐2‐(Di‐n‐Propylamino)Tetralin Binding to Pre‐ and Postsynaptic 5‐Hydroxytryptamine Sites in Various Regions of the Rat Brain , 1985, Journal of neurochemistry.

[4]  L. Iversen,et al.  REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I , 1966, Journal of neurochemistry.

[5]  D. Hoyer,et al.  5-HT1D receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in calf substantia nigra. , 1988, European journal of pharmacology.

[6]  R. Sekura,et al.  Altered activity of the inhibitory guanyl nucleotide-binding component (Ni) induced by pertussis toxin. Uncoupling of Ni from receptor with continued coupling of Ni to the catalytic unit. , 1984, The Journal of biological chemistry.

[7]  M. Hamon,et al.  Ca2+‐Guanine Nucleotide Interactions in Brain Membranes. II. Characteristics of [3H]Guanosine Triphosphate and [3H]β, γ‐Imidoguanosine 5′‐Triphosphate Binding and Catabolism in the Rat Hippocampus and Striatum , 1982, Journal of neurochemistry.

[8]  M. De Vivo,et al.  Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. , 1986, The Journal of pharmacology and experimental therapeutics.

[9]  J. Metcalfe,et al.  Transient complexes. A new structural model for the activation of adenylate cyclase by hormone receptors (guanine nucleotides/irradiation inactivation). , 1979, The Biochemical journal.

[10]  M. Caron,et al.  The mammalian beta 2-adrenergic receptor: reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system. , 1984, Biochemistry.

[11]  A. Gilman,et al.  Guanine nucleotide-binding regulatory proteins; mediators of transmembrane signaling , 1987 .

[12]  A. Herbet,et al.  Multiple receptors for serotonin in the rat brain. , 1980, Advances in biochemical psychopharmacology.

[13]  P. Bradley,et al.  Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine , 1986, Neuropharmacology.

[14]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[15]  N. Mahy,et al.  Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells. , 1988, The Journal of pharmacology and experimental therapeutics.

[16]  A. Herbet,et al.  Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. , 1978, Molecular pharmacology.

[17]  R. North,et al.  5-HT3 receptors are membrane ion channels , 1989, Nature.

[18]  R. Nicoll,et al.  A G protein couples serotonin and GABAB receptors to the same channels in hippocampus. , 1986, Science.

[19]  D. Kendall,et al.  5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants. , 1985, The Journal of pharmacology and experimental therapeutics.

[20]  J. Bockaert,et al.  5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. , 1988, European journal of pharmacology.

[21]  M. Vivo,et al.  Serotonin decreases population spike amplitude in hippocampal cells through a pertussis toxin substrate , 1987, Brain Research.

[22]  P. Conn,et al.  A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Sternweis,et al.  Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. , 1984, The Journal of biological chemistry.

[24]  M. Hamon,et al.  Pharmacological and Biochemical Characterization of Rat Hippocampal 5‐Hydroxytryptamine1A Receptors Solubilized by 3–[3–(Cholamidopropyl)dimethylammonio]‐1‐Propane Sulfonate (CHAPS) , 1988, Journal of neurochemistry.

[25]  W. Schlegel,et al.  Activation of adenylate cyclase in hepatic membranes involves interactions of the catalytic unit with multimeric complexes of regulatory proteins. , 1979, The Journal of biological chemistry.

[26]  L. Limbird,et al.  Solubilization of human platelet alpha-adrenergic receptors: evidence that agonist occupancy of the receptor stabilizes receptor--effector interactions. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[27]  5-Hydroxytryptamine receptor subtypes. , 1990, Pharmacology & toxicology.

[28]  M. Jackson,et al.  5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line , 1988, Neuron.

[29]  T. Pugsley,et al.  A rapid filtration assay for soluble receptors using polyethylenimine-treated filters. , 1983, Analytical biochemistry.

[30]  A. Couvineau,et al.  Solubilization of the liver vasoactive intestinal peptide receptor. Hydrodynamic characterization and evidence for an association with a functional GTP regulatory protein. , 1986, The Journal of biological chemistry.

[31]  Differential regulation of two molecular forms of a mu-opioid receptor type by sodium ions, manganese ions and by guanyl-5'-yl imidodiphosphate. , 1986, Journal of receptor research.

[32]  M. Caron,et al.  The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor , 1988, Nature.

[33]  R. Ciaranello,et al.  Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain. , 1988, Molecular pharmacology.

[34]  G. Aghajanian,et al.  Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons. , 1987, European journal of pharmacology.

[35]  David E. Clapham,et al.  Roles of G protein subunits in transmembrane signalling , 1988, Nature.

[36]  J. Bockaert,et al.  Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. , 1988, Molecular pharmacology.

[37]  T. Asano,et al.  Prevention of the agonist binding to gamma-aminobutyric acid B receptors by guanine nucleotides and islet-activating protein, pertussis toxin, in bovine cerebral cortex. Possible coupling of the toxin-sensitive GTP-binding proteins to receptors. , 1985, The Journal of biological chemistry.

[38]  M. Hamon,et al.  Chromatographic Analyses of the Serotonin 5‐HT1A Receptor Solubilized from the Rat Hippocampus , 1989, Journal of neurochemistry.

[39]  M. Caron,et al.  Effector coupling mechanisms of the cloned 5-HT1A receptor. , 1989, The Journal of biological chemistry.

[40]  M. Caron,et al.  An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins , 1987, Nature.

[41]  B. Roth,et al.  Multiple mechanisms of serotonergic signal transduction. , 1987, Life sciences.